Clinical Trial Update: Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

View source ↗

Summary

The update indicates Voraxaze (glucarpidase) has received marketing approval to treat methotrexate toxicity in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Voraxaze (glucarpidase)

Snippet

Sponsor: BTG International Inc. | Conditions: Neoplasms | Status: APPROVED_FOR_MARKETING